Recombinant EGFR (Cetuximab Biosimilar) antibody

Catalog No. ABIN5668058

This anti-EGFR (Cetuximab Biosimilar) antibody is a Human Monoclonal antibody detecting EGFR (Cetuximab Biosimilar) in FACS and BR. Suitable for Human.

Quick Overview for Recombinant EGFR (Cetuximab Biosimilar) antibody (ABIN5668058)

Target: EGFR (Cetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This EGFR (Cetuximab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Blocking Reagent (BR)

Clone: C225

Product Details anti-EGFR (Cetuximab Biosimilar) Antibody

Purpose: Anti-EGFR [C225 (Cetuximab)], Human IgG1, kappa

Specificity: Recognises human EGFR.

Characteristics:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Purity: > 98 % as determined by SDS-PAGE

Endotoxin Level: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands.

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for EGFR (Cetuximab Biosimilar)

Target: EGFR (Cetuximab Biosimilar)

Target Type: Biosimilar

Background: EGFR, ErbB-1, HER1, epidermal growth factor receptor

UniProt: P00533